BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//ARMI - ECPv6.17.4.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:ARMI
X-ORIGINAL-URL:https://www.armiusa.org
X-WR-CALDESC:Events for ARMI
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20260308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20261101T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20270314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20271107T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260922
DTEND;VALUE=DATE:20260924
DTSTAMP:20260914T184732Z
CREATED:20260914T184732Z
LAST-MODIFIED:20260914T184732Z
UID:10001813-1790035200-1790207999@www.armiusa.org
SUMMARY:Accelerating the Translation of Cell Therapy for Type 1 Diabetes
DESCRIPTION:ARMI | BioFabUSA will participate in the National Institute of Diabetes and Digestive and Kidney Diseases workshop\, “Accelerating the Translation of Cell Therapy for Type 1 Diabetes\,” taking place September 22–23\, 2026\, at the NIH campus in Bethesda\, Maryland. \nThe public workshop will bring together leaders from government\, academia\, industry and patient organizations to discuss best practices and recommendations for advancing the next generation of cell-replacement therapies for type 1 diabetes. Sessions will address nonclinical studies\, manufacturing and quality considerations\, clinical trial design and opportunities for collaboration in an AI-powered data environment. \nTom Bollenbach\, Ph.D.\, Chief Technology Officer at ARMI\, serves on the workshop planning committee and will moderate “Challenges and Opportunities in Manufacturing Cell-Replacement Therapies” on September 22. The session will examine early-stage chemistry\, manufacturing and controls considerations\, process and analytical development\, and large-scale manufacturing of cell therapies. \nOn September 23\, Bollenbach will also co-moderate “Collaborations in an Artificial Intelligence-Powered Big Data Era\,” focused on opportunities for pre-competitive collaboration\, data science\, AI and machine learning to help address shared challenges in cell-replacement therapy development. \nThe workshop is organized by NIDDK with participation from the U.S. Food and Drug Administration\, Breakthrough T1D\, academic researchers and industry leaders. \nLearn More
URL:https://www.armiusa.org/event/accelerating-the-translation-of-cell-therapy-for-type-1-diabetes/
LOCATION:The Lister Hill Center\, Building 38A\, Bethesda\, MD
CATEGORIES:ARMI,BioFabUSA
ATTACH;FMTTYPE=image/png:https://www.armiusa.org/wp-content/uploads/2022/05/Featuredinperson-e1653358665154.png
END:VEVENT
END:VCALENDAR